Clinical Trial Update: Pyrotinib Plus Neoadjuvant Chemotherapy in HR+/HER2-, HER4-High Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is assessing pyrotinib with neoadjuvant chemotherapy in hormone-receptor positive, HER2-negative, HER4-high breast cancer; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pyrotinib (pyrotinib)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Breast Cancer, Hormone-receptor Positive Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING